BTMD
NASDAQ
US
Biote Corp. - Class A common stock
$1.59
▲ +$0.16
(+11.19%)
Vol 379K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$118.7M
P/E
4.1
ROE
-1.6%
Margin
14.7%
D/E
334.58
Beta
1.15
52W
$2–$6
Wall Street Consensus
11 analysts · Apr 20263
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
81.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.05 | $0.06 | +$0.01 |
| Sep 2025 | $0.05 | $0.22 | +$0.17 |
| Jun 2025 | $0.06 | $0.18 | +$0.12 |
| Mar 2025 | $0.07 | $0.37 | +$0.30 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $49.8M | $49.0M | $48.9M | $48.0M | $46.4M |
| Net Income | $3.7M | $13.7M | $3.2M | $8.2M | $2.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -1.6% | -1.6% | -1.6% | -1.6% | -1.6% |
| P/E (TTM) | 6.50 | 4.69 | 4.71 | 4.53 | 3.96 | 4.12 |
| Net Margin | 6.5% | 15.7% | 15.7% | 15.7% | 14.7% | 14.7% |
| Gross Margin | 71.6% | 71.9% | 71.9% | 71.9% | 72.2% | 72.2% |
| D/E Ratio | — | 334.58 | 334.58 | 334.58 | 334.58 | 334.58 |
| Current Ratio | 0.98 | 0.98 | 0.98 | 0.98 | 1.01 | 1.01 |
Key Ratios
ROA (TTM)
24.9%
P/S (TTM)
0.61
EPS (TTM)
$0.86
CF/Share
$0.00
Rev Growth 3Y
+12.3%
52W High
$6.36
52W Low
$2.32
$2.32
52-Week Range
$6.36
Financial Health
Free Cash Flow
$5.2M
Net Debt
$85.8M
Cash
$24.1M
Total Debt
$109.9M
As of Dec 31, 2025
How does BTMD compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
BTMD valuation vs Pharmaceuticals peers
P/E ratio
4.1
▼
82%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.6
▼
88%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
BTMD profitability vs Pharmaceuticals peers
ROE
-1.6%
▲
97%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
14.7%
▲
131%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
72.2%
▲
6%
above
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
24.9%
▲
167%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
BTMD financial health vs Pharmaceuticals peers
D/E ratio
334.6
▲
21626%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.0
▼
70%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲
23%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
BTMD fundamentals radar
BTMD
Peer median
Industry
BTMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BTMD vs peers: key metrics
Latest News
No related news yet